Novartis (NOVN.S) is discussing options with banks for selling its near $14 billion (9.7 billion pounds) stake in rival Roche (ROG.S), potentially providing cash for new deals, though a sale is not imminent, according to two people familiar with the situation.
{iframe}http://uk.reuters.com/article/uk-novartis-roche-idUKKCN0XM0QF{/iframe}